A group of 162 patients with chronic open-angle glaucoma or ocular hypertension were
treated twice daily for up to 15 months with one of the following topical ophthalmic solutions …

Although twice-daily instillation of topical beta-blockers is the standard regimen for treatment
of increased intraocular pressure, once-daily therapy might improve patient compliance and …

• The ocular hypotensive effect and the safety of levobunolol hydrochloride (0.5% and 1%)
were compared with vehicle in this double-masked study of 42 patients with chronic open …

• In a one-year, double-masked, randomized study, the ocular hypotensive efficacy of twice-
daily treatment with 0.25% levobunolol hydrochloride or timolol maleate was evaluated in 78 …

In a double-masked, randomized, comparison titration study to determine the effective dose
of topically applied levobunolol, three concentrations of levobunolol (0.25%, 0.5%, and 1%) …

We studied the ocular hypotensive efficacy and safety of 0.5% levobunolol hydrochloride
and 0.5% timolol maleate administered topically once daily for 3 months in 91 patients (46 in …

Abstract In a 4-year, double-masked, parallel, multicenter study comparing the efficacy and
safety of levobunolol and timolol, 391 patients with open-angle glaucoma or ocular …

• Levobunolol hydrochloride (0.5% and 1%) and timolol maleate (0.5%) are being compared
in an ongoing, double-masked, randomized study of 141 patients with ocular hypertension …

In a three-month, double-masked, randomized clinical trial, we evaluated the once-daily
ocular hypotensive efficacy of 0.25% levobunolol and 0.25% timolol in 80 patients with open …

Data from two short-term double-masked studies using 24 and 16 subjects suggest that
topically applied levobunolol safely and effectively treats open-angle glaucoma and ocular …